Dr. Reddy's and Pharmazz inks agreement to market Centhaquine for hypovolemic shock in India
Centhaquine is a resuscitative agent presently indicated for the treatment of hypovolemic shock by DGCI
Centhaquine is a resuscitative agent presently indicated for the treatment of hypovolemic shock by DGCI
Dr Madhu will oversee Apollo's hospital business and will focus on continuing to deliver the world's best clinical outcomes
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis
Collaborative Research in AYUSH is extremely important as it bridges the gap between traditional knowledge and modern scientific research
The overall transaction is expected to conclude over next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals
Survodutide has potential to become best-in-class treatment for metabolic dysfunction-associated steatohepatitis
MoU to serve as the establishment of an Academic Collaboration in Ayurveda and Thai Traditional Medicine
Project achieves 30% reduction in hospital acquired infections and 24% reduction in the incidence of multi-drug resistant organisms
The acquisition of Aiolos includes AIO-001, a potentially best-in-class, long-acting antithymic stromal lymphopoietin (TSLP) monoclonal antibody
Subscribe To Our Newsletter & Stay Updated